Padagis LLC is a U.S.-based generic pharmaceutical company specializing in development and manufacturing of extended topical and specialty pharmaceutical products. Product portfolio includes prescription creams, ointments, gels, foams, sprays, patches, nasal treatments, and suppositories, with a focus on Paragraph IV generic products. Also manufactures naloxone nasal spray (awarded New York State Department of Health contract in 2025). Over 1,300 employees. Offers contract manufacturing, licensing, and joint venture partnerships.
Generic extended topical products with specialization in complex generics. Paragraph IV product development. Naloxone nasal spray manufacturing. Contract manufacturing, product acquisition, and licensing partnerships.
2 sites worldwide
Involvement in 5 clinical trials
No reviews available yet.
No documents available.